Janssen has announced that the FDA has approved its factor Xa inhibitor rivaroxaban for reduction of risk for major adverse CV events in patients with chronic CAD or peripheral artery disease.
The overall female population is ageing. Women in Canada can expect to live on average nearly 83 years, approximately 5
“We have chosen the theme in celebration of one of the greatest innovations in our discipline, the 50th anniversary of
Mnotho Mndebele, who had been in a critical condition in intensive care for four consecutive months prior to the ground-breaking